Keyphrases
Acute Lymphoblastic Leukemia
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Confidence Interval
100%
Donor Source
100%
Umbilical Cord Blood
44%
Relative Risk
38%
Unrelated Donor
22%
Blood Group
22%
Hematopoietic Stem Cell Transplantation
16%
Overall Survival
16%
Leukemia-free Survival
16%
HLA-matched Donor
11%
White Blood Cell Count
11%
Stem Cell Source
11%
M-group
11%
Donor Groups
11%
Working Diagnosis
11%
Graft-versus-host Disease (GvHD)
5%
Growth Factors
5%
Adult Patients
5%
Cytomegalovirus
5%
Demographic Characteristics
5%
Disease Pattern
5%
Myeloablative Conditioning
5%
Myeloablative
5%
HLA-mismatched Unrelated Donor
5%
Relapse Rate
5%
Regression Analysis
5%
Independent Risk Factors
5%
Relative Impact
5%
Transplant-related Mortality
5%
T-lineage
5%
DRB1
5%
Clinical Remission
5%
Induction Regimen
5%
High-risk Cytogenetics
5%
Normal Cytogenetics
5%
Blood Recipients
5%
Single-center Study
5%
Medicine and Dentistry
Cord Blood
100%
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Acute Lymphocytic Leukemia in Adults
100%
Blood Group
50%
Hematopoietic Stem Cell Transplantation
37%
Overall Survival
37%
Leukemia
37%
Stem Cell
25%
Disease
25%
Acute Lymphoblastic Leukemia
25%
Leukocyte
25%
Cell Count
25%
Transplantation
12%
Cytomegalovirus
12%
Myeloablative Conditioning
12%
Recurrence Risk
12%
Relative Survival
12%
Graft Versus Host Reaction
12%
Growth Factor
12%
Immunology and Microbiology
Umbilical Cord Blood
100%
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Blood Group
50%
Overall Survival
37%
Hematopoietic Stem Cell Transplantation
37%
Stem Cell
25%
Leukocyte Count
25%
Graft-Versus-Host Disease
12%
Lineages
12%
Growth Factor
12%
Cytomegalovirus
12%
Conditioning
12%